The decision comes as Schumer is now the Senate’s #2 recipient of pharmaceutical industry campaign cash.
By David Sirota, The Lever
Senate Majority Leader Chuck Schumer (D-N.Y.) let a U.S. Senate adviser kill key parts of Democrats’ promised drug pricing legislation, as Schumer has become the Senate’s second largest recipient of pharmaceutical industry cash.
On Saturday, the Senate’s parliamentary adviser Elizabeth MacDonough — who Schumer can remove — issued a non-binding advisory opinion saying Democrats should remove provisions in their spending bill that would punish drugmakers for inflating their prices for patients in private health insurance plans. The provision could have saved $40 billion, according to one estimate.
“The exclusion of the private insurance price limits means there is little left that will reduce costs for the vast majority of Americans who receive health insurance through their private sector employer,” reported Politico.
MacDonough also advised Democrats against including a provision in their legislation to cap out-of-pocket insulin costs at $35 a month for people on private insurance plans. Democrats ultimately held a failed vote to overrule her on the insulin cap.
Recent Posts
Democrats Are Already Throwing Immigrants Under The Bus
Take Action NowThe party’s rightward shift is solidified, as Democratic lawmakers support the Laken Riley Act, which makes it easier to…
Will The Ceasefire In Gaza Hold?
Take Action NowThe chances for durable peace may depend on Trump’s whims.By Joshua Leifer, DissentOn Sunday, after a delay of…
There’s No Such Thing As A Good Billionaire
Take Action Now Democrats want us to believe that there is some cohort of “good billionaires” who can be relied upon to fight for political progress.…
Anti-Immigrant Legislation Is A Boon For The Prison Industry
Take Action NowThe Laken Riley Act is an assault on due process, undermining all of our rights to make for-profit prison CEOs richer.……